I don’t have a fully convincing answer, but some investors maybe hesitant to own the stock when the phase-1 data for EDP-235 (COVID protease inhibitor) are due any day.
ENTA has always been a volatile stock because the trading volume is so low. (There are only 24.7M fully-diluted shares.)
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.